Glucose-6-phosphate dehydrogenase deficiency, chlorproguanil-dapsone with artesunate and post-treatment haemolysis in African children treated for uncomplicated malaria-Reference-Cited by-同舟云学术

Glucose-6-phosphate dehydrogenase deficiency, chlorproguanil-dapsone with artesunate and post-treatment haemolysis in African children treated for uncomplicated malaria

Published:2012-04-30 Issue:1 Volume:11 Page:
ISSN:1475-2875
Container-title:Malaria Journal
language:en
Short-container-title:Malar J

Author:

Van Malderen Carine,Van Geertruyden Jean-Pierre,Machevo Sonia,González Raquel,Bassat Quique,Talisuna Ambrose,Yeka Adoke,Nabasumba Carolyn,Piola Patrice,Daniel Atwine,Turyakira Eleanor,Forret Pascale,Van Overmeir Chantal,Van Loen Harry,Robert Annie,D’ Alessandro Umberto

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Parasitology

Link

http://link.springer.com/content/pdf/10.1186/1475-2875-11-139.pdf

Reference31 articles.

1. Tiono AB, Dicko A, Ndububa DA, Agbenyega T, Pitmang S, Awobusuyi J, Pamba A, Duparc S, Goh LE, Harrell E, Carter N, Ward SA, Greenwood B, Winstanley PA: Chlorproguanil-dapsone-artesunate versus chlorproguanil-dapsone: a randomized, double-blind, phase III trial in African children, adolescents, and adults with uncomplicated Plasmodium falciparum malaria. Am J Trop Med Hyg. 2009, 81: 969-978. 10.4269/ajtmh.2009.09-0351.

2. Alloueche A, Bailey W, Barton S, Bwika J, Chimpeni P, Falade CO, Fehintola FA, Horton J, Jaffar S, Kanyok T, Kremsner PG, Kublin JG, Lang T, Missinou MA, Mkandala C, Oduola AM, Premji Z, Robertson L, Sowunmi A, Ward SA, Winstanley PA: Comparison of chlorproguanil-dapsone with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in young African children: double-blind randomised controlled trial. Lancet. 2004, 363: 1843-1848. 10.1016/S0140-6736(04)16350-2.

3. Mutabingwa T, Nzila A, Mberu E, Nduati E, Winstanley P, Hills E, Watkins W: Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania. Lancet. 2001, 358: 1218-1223. 10.1016/S0140-6736(01)06344-9.

4. Looareesuwan S, Imwong M, Wilairatana P: Chlorproguanil-dapsone for malaria in Africa. Lancet. 2004, 363: 1838-1839. 10.1016/S0140-6736(04)16390-3.

5. Premji Z, Umeh RE, Owusu-Agyei S, Esamai F, Ezedinachi EU, Oguche S, Borrmann S, Sowunmi A, Duparc S, Kirby PL, Pamba A, Kellam L, Guiguemdé R, Greenwood B, Ward SA, Winstanley PA: Chlorproguanil-dapsone-artesunate versus artemether-lumefantrine: a randomized, double-blind phase III trial in African children and adolescents with uncomplicated Plasmodium falciparum malaria. PLoS One. 2009, 4: e6682-10.1371/journal.pone.0006682.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenomic Determinants of Adverse Drug Effects: A Systematic Review and Meta-analysis;In Vivo;2024

2. The medication for pneumocystis pneumonia with glucose-6-phosphate dehydrogenase deficiency patients;Frontiers in Pharmacology;2022-09-07

3. Neuroprotective effect of dapsone in patients with aneurysmal subarachnoid hemorrhage: a prospective, randomized, double-blind, placebo-controlled clinical trial;Neurosurgical Focus;2022-03

4. Biguanides drugs: Past success stories and promising future for drug discovery;European Journal of Medicinal Chemistry;2021-11

5. Clinical Application of Pharmacogenetic Markers in the Treatment of Dermatologic Pathologies;Pharmaceuticals;2021-09-06